<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02707653</url>
  </required_header>
  <id_info>
    <org_study_id>2001</org_study_id>
    <nct_id>NCT02707653</nct_id>
  </id_info>
  <brief_title>Sublingual Misoprostol for the Treatment of Incomplete Abortion: Operations Research</brief_title>
  <official_title>Sublingual Misoprostol for the Treatment of Incomplete Abortion: Operations Research</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gynuity Health Projects</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Department of Medical Research, Lower Myanmar</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Gynuity Health Projects</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will investigate the use of misoprostol for first-line treatment of incomplete
      abortion at tertiary hospitals in Myanmar.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This open-label feasibility study seeks to examine the potential of 400Î¼g sublingual
      misoprostol for the treatment of incomplete abortion provided at tertiary hospitals.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 2016</start_date>
  <completion_date type="Actual">November 2016</completion_date>
  <primary_completion_date type="Actual">November 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of women with complete uterine evacuation with study medication alone.</measure>
    <time_frame>14 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of women experiencing side effects</measure>
    <time_frame>7-14 days</time_frame>
    <description>occurrence of side effects, if any, including fever, chills, nausea, vomiting, headache, diarrhea, and pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of self-reported acceptability of treatment</measure>
    <time_frame>7-14 days</time_frame>
    <description>Woman's satisfaction with the treatment, woman's likelihood to use the treatment in the future, woman's likelihood of recommending the treatment to a friend, providers' satisfaction with the treatment, likelihood provider would recommend the treatment in a similar situation.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Incomplete Abortion</condition>
  <arm_group>
    <arm_group_label>Miso</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Misoprostol 400 s/l</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Misoprostol</intervention_name>
    <description>400 mcg sublingual misoprostol</description>
    <arm_group_label>Miso</arm_group_label>
    <other_name>cytotec</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Confirmed incomplete abortion

          2. No known contraindications to the study drug

          3. Uterine size no larger than 12 weeks at time of presentation for care

          4. No signs of severe infection, defined as at least two of the following:

               -  foul smelling discharge,

               -  fever &gt; 38 degrees C, 100 degrees Fahrenheit

               -  uterine tenderness.

          5. No hemodynamic disturbances (pulse &gt;110/min and systolic bp &lt;100)

          6. General good health

          7. Agree to comply with study procedures including return for follow up visit

          8. Live or work within one hour from a study site

          9. Willing and able to sign consent forms

        Exclusion Criteria:

        1. Inability to provide informed consent
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Central Woman's Hospital</name>
      <address>
        <city>Yangon</city>
        <country>Myanmar</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Thingyan Sanpya Hospital</name>
      <address>
        <city>Yangon</city>
        <country>Myanmar</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Myanmar</country>
  </location_countries>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>February 19, 2016</study_first_submitted>
  <study_first_submitted_qc>March 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 14, 2016</study_first_posted>
  <last_update_submitted>June 8, 2018</last_update_submitted>
  <last_update_submitted_qc>June 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Abortion, Incomplete</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Misoprostol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

